Related Experiment Video
Updated: Sep 20, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Racial differences in lifetime healthcare costs associated with obesity-related multimorbidity among the U.S.
Preeti Pushpalata Zanwar1,2,2,3, Mei Wang4, Nathan Logan5
1Applied Health Economics and Outcomes Research, Jefferson College of Population Health, Thomas Jefferson University, Philadelphia, PA.
Background:
Obesity is a costly cause of morbidity and disability. Previous research has well documented that Black persons bear a disproportionate financial burden of obesity-related multimorbidity (ORM); however, healthcare costs have not been examined over the lifespan.
Objective:
Among U.S. general population age ≥40 years, we quantified racial difference in 1) lifetime healthcare costs (LHC's), and 2) lifetime healthcare cost differential (LCD) associated with ORM.
Methods:
We used data from the Medical Expenditure Panel Survey, 2008-2012, and targeted four obesity-related diseases (ORDs): diabetes, hypertension, coronary heart disease, and stroke. A published Markov model was used to model individuals' life histories of ORDs and to compute LHC's. LCD associated with ORM was computed by taking the difference between LHC for those with ORM and LHC for members without ORD. Racial differences were quantified by taking the differences in LHC or LCD between White and Black men/women.
Results:
We included 53,035 Black and White individuals representing 97,229,611 (se=2,104,365) U.S. Black (12.4%) and White (87.6%) populations aged ≥40 years. ORM was more prevalent in the Black (21.2%) than the White populations (13.4%). Racial difference in LHC's for women/men with ORM and LCDs associated with ORM (2012$) was $31,035/43,595 and $11,350/26,948 for age 40-49, $21,567/25,615 and $3,846/9,808 for 50-59, $9,863/18,515 and -$2,566/7,426 for 60-69, -$8,220/16,285 and -$11,524/3,865 for 70-79.
Conclusions:
Racial differences in LHC's and LCD associated with ORM persist and the scale varies by subpopulation. Future interventions designed to prevent/manage ORM are crucial to prioritize populations burdening with high LHC's and health disparities.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Bias in Epidemiological Studies
Lifestyle Factors and Health
Benefits of Physical Activity
Physical activity, whether through structured exercise or casual activities like walking, biking, or dancing, is a cornerstone of a...
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution